Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition.

Oncoimmunology · 2020 · PMC7458667 · PMID 32923123

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Nevertheless, groups receiving virotherapy displayed a clear trend for increased expression of immunostimulatory cytokines (IFNg, TNFa, IL-2, granzyme B, and CXCL10) ( Figure 2a-f , Supp.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.